MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$27,052
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from sale of common sto...
Expenses allocated by sanovas on...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Net loss
Advances from related parties, n...
Increase in accounts payable and...
Decrease in lease liability
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-307,397
-590,489
-623,127
-568,791
Stock-based compensation expense
24,782
210,016
281,246
277,226
Depreciation expense
-
-
0
0
Amortization of right of use asset
-
-
-
640
Amortization of rou asset
642
642
2,563
-
Expenses allocated by sanovas on behalf of company
165,375
165,375
165,375
165,375
Increase in accounts payable and accrued liabilities
-20,559
104,757
47,131
20,947
Decrease in lease liability
-474
-474
-446
-194
Increase in accrued interest
960
960
960
960
Total adjustments
170,726
481,276
494,908
464,954
Net cash (used in) operating activities
-136,671
-109,213
-128,219
-103,837
Proceeds from collection of stock subscription receivable
0
125,000
0
0
Proceeds from sale of common stock
200,000
-
212,000
100,000
Advances from related parties, net
-36,277
-30,381
-69,099
88,163
Net cash provided by financing activities
163,723
94,619
142,901
103,090
Net (decrease) in cash
27,052
-14,594
14,682
-747
Cash at beginning of period
180
14,774
92
6,060
Cash at end of period
27,232
180
14,774
92
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
common stock
$200,000
(132.56%↑ Y/Y)
Net cash provided by
financing activities
$163,723
(-49.01%↓ Y/Y)
Canceled cashflow
$36,277
Expenses allocated by
sanovas on behalf of...
$165,375
(-50.00%↓ Y/Y)
Stock-based compensation
expense
$24,782
(-94.86%↓ Y/Y)
Increase in accrued
interest
$960
(-50.00%↓ Y/Y)
Amortization of rou asset
$642
Net (decrease) in
cash
$27,052
(618.14%↑ Y/Y)
Canceled cashflow
$136,671
Advances from related
parties, net
-$36,277
(-142.64%↓ Y/Y)
Total adjustments
$170,726
(-81.25%↓ Y/Y)
Canceled cashflow
$21,033
Net cash (used in)
operating activities
-$136,671
(58.11%↑ Y/Y)
Canceled cashflow
$170,726
Increase in accounts
payable and accrued...
-$20,559
(-121.73%↓ Y/Y)
Decrease in lease
liability
-$474
(-36.21%↓ Y/Y)
Net loss
-$307,397
(75.14%↑ Y/Y)
Buy us a coffee
RetinalGenix Technologies Inc. (RTGN)
RetinalGenix Technologies Inc. (RTGN)